波浪生命科学 WVE
$3.37 +$0.15 (+4.50%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.34 -0.74%
开盘$3.25
昨收$3.22
当日区间$3.23 – $3.42
成交量2.21M
市值$663.68M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$13.16M+72.9% YoY
营业利润-$66.05M-17.2% YoY
净利润-$61.91M-15.0% YoY
摊薄每股收益-$0.30+6.3% YoY
自由现金流-$60.16M-33.9% YoY
经营现金流-$60.14M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-320.9%
净利率-296.9%
净资产收益率-80.0%
资产收益率-56.2%
投入资本回报率-71.4%
流动比率8.38
负债/资产比率20.9%
现金及投资$430.75M
总负债$38.90M
净现金（净负债）$391.85M
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $13.16M | $2.27M | $38.25M | $42.73M | $17.25M |
| 营业总收入 | $13.16M | $2.27M | $38.25M | $42.73M | $17.25M |
| 营业费用 | $79.21M | $76.07M | $69.54M | $258.11M | $73.71M |
| 销售及管理费用 | $25.36M | $24.78M | $22.10M | $75.33M | $20.90M |
| -管理费用 | $25.36M | $24.78M | $22.10M | $75.33M | $20.90M |
| 研发费用 | $53.84M | $51.29M | $47.44M | $182.78M | $52.81M |
| 营业利润 | -$66.05M | -$73.80M | -$31.30M | -$215.38M | -$56.47M |
| 非经营性利息净收入（支出） | $4.38M | $4.72M | $5.29M | – | – |
| 非经营性利息收入 | $4.38M | $4.72M | $5.29M | – | – |
| 其他收入（支出） | -$243,000.00 | -$275,000.00 | -$80,000.00 | $11.01M | $10.71M |
| 其他非经营性收入（支出） | -$243,000.00 | -$275,000.00 | -$80,000.00 | $527,000.00 | $234,000.00 |
| 税前利润 | -$61.91M | -$69.36M | -$26.09M | -$204.38M | -$53.18M |
| 税费 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 净利润 | -$61.91M | -$69.36M | -$26.09M | -$204.38M | -$53.18M |
| 持续经营利润 | -$61.91M | -$69.36M | -$26.09M | -$204.38M | -$53.18M |
| 归属母公司净利润 | -$61.91M | -$69.36M | -$26.09M | -$204.38M | -$53.18M |
| 归属普通股股东净利润 | -$61.91M | -$69.36M | -$26.09M | -$204.38M | -$53.18M |
| 基本每股收益 | -$0.30 | -$0.34 | -$0.13 | -$1.21 | -$0.30 |
| 摊薄每股收益 | -$0.30 | -$0.34 | -$0.13 | -$1.21 | -$0.30 |
| 证券出售收益 | – | – | – | $10.48M | – |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $507.93M | $558.32M | $583.54M | $638.50M | $638.50M |
| 流动资产合计 | $458.63M | $507.51M | $561.27M | $614.81M | $614.81M |
| 现金及现金等价物与短期投资 | $430.75M | $490.60M | $544.59M | $602.07M | $602.07M |
| -现金及现金等价物 | $197.32M | $368.01M | $544.59M | $602.07M | $602.07M |
| -短期投资 | $233.43M | $122.59M | – | – | – |
| 应收款 | $12.00M | $888,000.00 | $0.00 | $1.28M | $1.28M |
| -应收账款 | $12.00M | $888,000.00 | $0.00 | $1.28M | $1.28M |
| 预付资产 | $11.56M | $12.12M | $13.23M | $8.40M | $8.40M |
| 其他流动资产 | $4.33M | $3.90M | $3.46M | $3.08M | $3.08M |
| 非流动资产合计 | $49.30M | $50.81M | $22.27M | $23.69M | $23.69M |
| 固定资产净值 | $44.33M | $46.33M | $18.07M | $19.86M | $19.86M |
| -固定资产原值 | $95.72M | $97.15M | $68.42M | $69.39M | $69.39M |
| -累计折旧 | -$51.39M | -$50.82M | -$50.35M | -$49.52M | -$49.52M |
| 投资及预付款 | $263,000.00 | – | – | – | – |
| -可供出售证券 | $263,000.00 | – | – | – | – |
| 其他非流动资产 | $4.71M | $4.48M | $4.20M | $3.82M | $3.82M |
| 负债合计 | $105.99M | $104.80M | $71.81M | $120.14M | $120.14M |
| 流动负债合计 | $54.76M | $50.82M | $49.83M | $95.07M | $95.07M |
| 应付款 | $19.30M | $20.36M | $19.06M | $15.70M | $15.70M |
| -应付账款 | $19.30M | $20.36M | $19.06M | $15.70M | $15.70M |
| 一年内应计费用 | $9.07M | $7.87M | $7.52M | $8.48M | $8.48M |
| 短期债务及融资租赁负债 | $4.38M | $3.51M | $8.33M | $8.36M | $8.36M |
| -一年内到期融资租赁负债 | $4.38M | $3.51M | $8.33M | $8.36M | $8.36M |
| 一年内递延负债 | $9.11M | $8.70M | $9.40M | $44.44M | $44.44M |
| 非流动负债合计 | $51.23M | $53.99M | $21.98M | $25.08M | $25.08M |
| 长期债务及融资租赁负债 | $38.90M | $40.08M | $7.39M | $9.41M | $9.41M |
| -长期融资租赁负债 | $38.90M | $40.08M | $7.39M | $9.41M | $9.41M |
| 一年以上递延负债 | $12.34M | $13.90M | $14.60M | $7.80M | $7.80M |
| 可转换优先证券 | $0.00 | $0.00 | $0.00 | $7.87M | $7.87M |
| 股东权益合计 | $401.94M | $453.52M | $511.73M | $518.36M | $518.36M |
| 股东权益 | $401.94M | $453.52M | $511.73M | $518.36M | $518.36M |
| 股本 | $197,000.00 | $1.63B | $1.63B | $1.62B | $1.62B |
| -普通股 | $197,000.00 | $1.63B | $1.63B | $1.62B | $1.62B |
| -优先股 | $0.00 | – | – | – | – |
| 资本公积 | $1.89B | $248.16M | $237.43M | $228.37M | $228.37M |
| 留存收益 | -$1.48B | -$1.42B | -$1.35B | -$1.33B | -$1.33B |
| 不影响留存收益的损益 | -$565,000.00 | -$172,000.00 | -$254,000.00 | -$250,000.00 | -$250,000.00 |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$60.14M | -$53.58M | -$59.55M | -$187.49M | -$33.78M |
| 持续经营经营活动现金流净额 | -$60.14M | -$53.58M | -$59.55M | -$187.49M | -$33.78M |
| 持续经营净利润 | -$61.91M | -$69.36M | -$26.09M | -$204.38M | -$53.18M |
| 折旧、折耗与摊销 | $2.29M | $2.37M | $2.31M | $8.85M | $2.26M |
| 其他非现金项目 | -$531,000.00 | – | – | – | – |
| 营运资金变动 | -$10.28M | $2.74M | -$44.83M | -$16.94M | $9.79M |
| -应收款变动 | -$11.11M | -$888,000.00 | $1.28M | $146,000.00 | $8.72M |
| -预付资产变动 | $565,000.00 | $1.10M | -$4.83M | $1.15M | -$1.74M |
| -应付账款及应计费用变动 | $2.40M | $6.77M | -$10.23M | $4.92M | $11.23M |
| -其他流动资产变动 | -$656,000.00 | -$722,000.00 | -$751,000.00 | $4.31M | -$452,000.00 |
| -其他流动负债变动 | -$319,000.00 | -$2.14M | -$2.05M | -$7.64M | -$2.01M |
| -其他营运资金变动 | -$1.16M | -$1.39M | -$28.25M | -$19.83M | -$5.97M |
| 投资活动现金流净额 | -$110.86M | -$123.45M | -$438,000.00 | -$718,000.00 | $1,000.00 |
| 持续经营投资活动现金流净额 | -$110.86M | -$123.45M | -$438,000.00 | -$718,000.00 | $1,000.00 |
| 固定资产购置及出售净额 | -$15,000.00 | -$884,000.00 | -$438,000.00 | -$718,000.00 | $1,000.00 |
| 投资购置及出售净额 | -$110.84M | – | – | – | – |
| 筹资活动现金流 | $433,000.00 | $330,000.00 | $2.53M | $488.24M | $439.70M |
| 持续经营筹资活动现金流净额 | $433,000.00 | $330,000.00 | $2.53M | $488.24M | $439.70M |
| 普通股发行净额 | $0.00 | $0.00 | $0.00 | $472.49M | $429.91M |
| 股票期权行使所得 | $433,000.00 | $330,000.00 | $2.53M | $15.75M | $9.78M |
| 期末现金余额 | $201.13M | $371.82M | $548.41M | $605.87M | $605.87M |
| 现金净变动 | -$170.57M | -$176.71M | -$57.46M | $300.02M | $405.92M |
| 期初现金余额 | $371.82M | $548.41M | $605.87M | $305.84M | $200.01M |
| 汇率变动影响 | -$125,000.00 | $123,000.00 | -$4,000.00 | $12,000.00 | -$60,000.00 |
| 自由现金流 | -$60.16M | -$54.47M | -$59.99M | -$188.21M | -$33.78M |
暂无评论——快来第一个聊聊 WVE。